The downgrade from Overweight to Neutral and the significant reduction in price target by JP Morgan analyst Anupam Rama indicate a less optimistic outlook for Annexon's stock. This could lead to a short-term negative impact on the stock price as investors may adjust their positions based on the new rating and price target.